Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2011 Nov;84(5):e1-4.
doi: 10.1016/j.contraception.2011.05.003. Epub 2011 Jun 16.

Matched-pairs analysis of ovarian suppression during oral vs. vaginal hormonal contraceptive use

Kelsey A Petrie  1 , Anu H Torgal, Carolyn L Westhoff
Affiliations
Randomized Controlled Trial

Matched-pairs analysis of ovarian suppression during oral vs. vaginal hormonal contraceptive use

Kelsey A Petrie et al. Contraception. 2011 Nov.

Abstract

Background: This study was conducted to compare ovarian suppression during oral vs. vaginal hormonal contraceptive use. Secondary aims included comparison of endometrial thickness and bleeding patterns.

Methods: In two open-label trials assessing ovarian suppression, 33 compliant women completed both studies. They first used oral contraceptive pills (OCs) [randomized to either 20 mcg ethinyl estradiol (EE)/100 mcg levonorgestrel (LNG) or 30 mcg EE/150 mcg LNG] and subsequently used contraceptive vaginal rings (CVRs) (daily release of 15 mcg EE/120 mcg etonogestrel), all 21/7-day regimens. Participants had at least one run-in cycle using each contraceptive method prior to evaluation. During one cycle of each method, women underwent biweekly transvaginal sonography to measure ovarian follicular diameters and endometrial thickness. We also noted presence of a corpus luteum or a ruptured follicle as a marker of ovulation. Participants recorded bleeding days on paper calendars. We used matched-pairs analyses as appropriate.

Results: During follow-up, we identified at least one ovarian follicle ≥8 mm in 20/33 (61%) OC users and 12/33 (36%) CVR users (matched-pairs analysis, p=.02). Similar trends were seen for larger follicles; however, we had limited statistical power to evaluate these differences. Median follicular diameter among OC users was larger than median follicular diameter among CVR users (p=.01). We did not observe a corpus luteum or ruptured follicle in any participant during either study. Endometrial thickness was similar during OC and CVR use (mean 4.1±1.4 vs. 4.1±1.6 mm, p=.9), as was the number of bleeding or spotting days (mean 2.1±2.4 vs. 1.9±2.1, p=.8). Oral contraceptive pill dose was unrelated to follicle diameter, endometrial thickness or bleeding.

Conclusions: Ovarian follicles ≥8 mm were more common in 33 compliant women during OC use than during CVR use, indicating that CVR use results in greater ovarian suppression than OC use.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Hou MY, Hurwitz S, Kavanagh E, Fortin J, Goldberg AB. Using daily text-message reminders to improve adherence with oral contraceptives: A randomized controlled trial. Am J Obstet and Gynecol. 2010;116:633–640. - PubMed
    1. Torgal A, Mayeda E, Dragoman M, Linker D, Westhoff C. Ovarian follicular development during extended use of NuvaRing® in normal weight and obese women. Contraception. 2010;82:199.
    1. Mulders T, Dieben T. Use of the novel combined contraceptive vaginal ring NuvaRing® for ovulation inhibition. Fertil Steril. 2001;75:865–870. - PubMed
    1. Mulders T, Dieben T, Bennink H. Ovarian function with a novel combined contraceptive vaginal ring. Hum Reprod. 2002;17:2594–2599. - PubMed
    1. Dieben T, Roumen J, Apter D. Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring. Am J Obstet Gynecol. 2002;100:585–593. - PubMed

Publication types